The US Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.

The U.S. Food and Drug Administration (FDA) has released several important updates addressing new medication approvals and ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Protagonist Therapeutics (PTGX – Research Report) and Roche ...

Additionally, please note the following Stroke specific guidelines. Optional: Stroke posts about its published articles on Facebook and Twitter. If you would like us to include an author or department ...